iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare iSpecimen to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, valuation, profitability and earnings. Profitability This table compares iSpecimen […]